Will Amy Madigan win Best Supporting Actress at the Oscars?

Step 1: Precursor Correlation Analysis

Amy Madigan has won the most predictive precursor - the SAG Award, which historically correlates with Oscar wins at ~80%. However, this is a split precursor scenario:

• SAG: Amy Madigan (Weapons)
• BAFTA: Wunmi Mosaku (Sinners)
• Golden Globe: Teyana Taylor (One Battle After Another)
• Critics Choice: Amy Madigan (Weapons)
• NYFCC: Amy Madigan (Weapons)

Madigan leads 3-1-1 in major precursors, with the crucial SAG win. Historical data shows SAG is the strongest single predictor for acting Oscars due to voting body overlap (actors voting for actors).

Step 2: Contextual Factors Analysis

POSITIVE for Madigan:

• SAG win (80% correlation historically)
• Unprecedented "overdue veteran" narrative (40-year gap breaks all records)
• Age 75 - Academy loves honoring late-career veterans
• Critics Choice + NYFCC wins show critical support
• Vote-splitting: Two nominees from "Sentimental Value" will cancel each other out

NEGATIVE for Madigan:

• "Lone nominee" from Weapons (only 1 nomination total) - suggests limited Academy support for the film
• Horror genre faces historical Academy bias
• Brief screen time (14 minutes) though not unprecedented for winners
• Split precursors increase upset probability significantly

COMPETITOR STRENGTH:

• Wunmi Mosaku: From "Sinners" with record 16 nominations - massive institutional support
• Teyana Taylor: Golden Globe winner, could ride late momentum

Step 3: Supporting Category Volatility

Supporting actress historically has ~30% upset rate (higher than lead categories at ~20%). When precursors split, this increases further. However, SAG remains the most reliable single indicator.

Step 4: Probability Calculation

Base SAG correlation: 80% Adjustments:

• Split precursors: -15% (increases uncertainty)
• Lone nominee disadvantage: -10% (limited film support)
• Powerful veteran narrative: +5% (Academy loves this story)
• Vote-splitting benefit: +5% (eliminates 2 competitors effectively)
• Genre bias against horror: -5%
• Critics wins supporting SAG: +5%

Adjusted probability: 80% - 15% - 10% + 5% + 5% - 5% + 5% = 65%

However, market efficiency suggests the 46.5% odds incorporate information I may not have. The market and expert consensus clustering around 42-46.5% indicates informed skepticism about the SAG win being decisive.

Final estimate: 48% - slightly above market odds due to SAG win's historical power, but acknowledging the significant headwinds from split precursors and lone nominee status.

SLIGHT EDGE ON MADIGAN: The market at 46.5% appears to slightly undervalue Madigan's chances given the SAG win's 80% historical correlation. My estimate of 48% suggests minimal edge (+1.5 percentage points), barely worth acting on given transaction costs and uncertainty.

The market and expert consensus (42-46.5%) are remarkably aligned, suggesting efficient information processing. The skepticism about Madigan as a true favorite likely stems from:

1. Lone nominee status (red flag for Academy support)
2. Split precursors (no consensus winner)
3. Horror genre bias
4. Competition from 16-nomination juggernaut 'Sinners'

However, the market may be slightly overcorrecting for these concerns. The SAG win remains the single most predictive data point, and the 40-year narrative is historically unprecedented. Supporting actress upsets typically occur when there's NO clear precursor leader - but Madigan has won 3 of 5 major precursors including the most important one.

RECOMMENDATION: At 46.5% odds, there's marginal value on Madigan but not enough to warrant strong conviction. This is essentially a coin flip with slight edge to the SAG winner. The bet is fairly priced, perhaps 1-2 percentage points undervalued. A prudent bettor might take small position on Madigan at these odds, but this is not a strong value opportunity.

NOTE: Results will be known in 3 days (March 15, 2026 ceremony), so this is a very short-term proposition with no new data expected before resolution.